ATE76750T1 - Anwendung eines prostaglandins in mischung mit einem adrenergischen blocker zur verminderung des augen-innendruckes. - Google Patents

Anwendung eines prostaglandins in mischung mit einem adrenergischen blocker zur verminderung des augen-innendruckes.

Info

Publication number
ATE76750T1
ATE76750T1 AT88104999T AT88104999T ATE76750T1 AT E76750 T1 ATE76750 T1 AT E76750T1 AT 88104999 T AT88104999 T AT 88104999T AT 88104999 T AT88104999 T AT 88104999T AT E76750 T1 ATE76750 T1 AT E76750T1
Authority
AT
Austria
Prior art keywords
prostaglandin
eye
intraocular pressure
adrenegic
blocker
Prior art date
Application number
AT88104999T
Other languages
English (en)
Inventor
Laszlo Z Bito
Johan Wilhelm Stjernschantz
Original Assignee
Univ Columbia
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21876714&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE76750(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Columbia, Pharmacia Ab filed Critical Univ Columbia
Application granted granted Critical
Publication of ATE76750T1 publication Critical patent/ATE76750T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT88104999T 1987-04-03 1988-03-28 Anwendung eines prostaglandins in mischung mit einem adrenergischen blocker zur verminderung des augen-innendruckes. ATE76750T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3448487A 1987-04-03 1987-04-03
EP88104999A EP0286903B2 (de) 1987-04-03 1988-03-28 Anwendung eines Prostaglandins in Mischung mit einem adrenergischen Blocker zur Verminderung des Augen-Innendruckes

Publications (1)

Publication Number Publication Date
ATE76750T1 true ATE76750T1 (de) 1992-06-15

Family

ID=21876714

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88104999T ATE76750T1 (de) 1987-04-03 1988-03-28 Anwendung eines prostaglandins in mischung mit einem adrenergischen blocker zur verminderung des augen-innendruckes.

Country Status (9)

Country Link
EP (1) EP0286903B2 (de)
JP (1) JP2726672B2 (de)
AT (1) ATE76750T1 (de)
AU (1) AU607981B2 (de)
CA (1) CA1314220C (de)
DE (1) DE3871596T3 (de)
ES (1) ES2042625T5 (de)
GR (2) GR3004794T3 (de)
HU (1) HU211835A9 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334168C (en) * 1988-04-26 1995-01-31 Louis M. De Santis Antiglaucoma compositions containing combinations of .alpha.-2 agonists and .beta. blockers
US5173507A (en) * 1988-07-18 1992-12-22 Alcon Laboratories, Inc. Prostaglandin combinations in glaucoma therapy
US4994274A (en) * 1989-07-27 1991-02-19 Allergan, Inc. Intraocular pressure reducing 11,15-diacyl prostaglandins and method of using
US5028624A (en) * 1989-07-27 1991-07-02 Allergan, Inc. Intraocular pressure reducing 9,15-diacyl prostaglandins
CA2021316C (en) * 1989-07-27 2000-10-24 Ming Fai Chan Intraocular pressure reducing 11-acyl prostaglandins
US5055467A (en) * 1989-11-13 1991-10-08 Allergan, Inc. Pharmaceutical epinephrine-pilocarpine compounds
US5198545A (en) * 1989-11-13 1993-03-30 Allergan, Inc. Pharmaceutical epinephrine-pilocarpine compounds and process of preparation thereof
US5011856A (en) * 1990-03-12 1991-04-30 Allergan, Inc. Use of prostaglandin F3 α as an ocular hypotensive agent
ES2059058T3 (es) * 1990-05-22 1994-11-01 R Tech Ueno Ltd Combinacion sinergica para uso oftalmico.
EP0458590B1 (de) * 1990-05-22 1996-01-10 R-Tech Ueno Ltd. Behandlung von intraokularem Druck mit einer synergischen Kombination
CA2042934C (en) * 1990-05-22 2002-04-23 Ryuji Ueno Treatment of ocular hypertension with an ocular synergistic combination
US5238961A (en) * 1990-06-14 1993-08-24 Allergan, Inc. Pgf 1-alcohols and their use as ocular hypotensives
TW210287B (de) * 1991-03-01 1993-08-01 Kabushikaisha Ueno Seiyaku Oyo Kenkyujo
DK0561073T3 (da) * 1992-03-19 2001-11-12 R Tech Ueno Ltd Behandling af øjenhypertension
JPH06107547A (ja) * 1992-10-01 1994-04-19 Aarutetsuku Ueno:Kk 眼科用組成物
JP3002258B2 (ja) * 1992-10-13 2000-01-24 アルコン ラボラトリーズ， インコーポレイテッド 緑内障（ｇｌａｕｃｏｍａ）治療のための、プロスタグランジンとクロニジン誘導体の組合わせ
US5574066A (en) * 1992-10-28 1996-11-12 Allergan Intraocular pressure reducing 15-acyl prostaglandins
SE9402816D0 (sv) * 1994-08-24 1994-08-24 Pharmacia Ab Method and meams for drug administration
US5698733A (en) * 1994-09-30 1997-12-16 Alcon Laboratories, Inc. Use of 9-deoxy prostaglandin derivatives to treat glaucoma
AU746893B2 (en) * 1998-01-23 2002-05-02 Merck Sharp & Dohme B.V. Method for increasing oxygen tension in the optic nerve and retina
JP4261912B2 (ja) * 2001-04-19 2009-05-13 テイカ製薬株式会社 薬剤および薬剤キット
TWI298257B (en) * 2001-05-31 2008-07-01 Allergan Inc Hypotensive lipid and timolol compositions and methods of using same
AU2007200821A1 (en) * 2001-05-31 2007-03-15 Allergan, Inc. Hypotensive lipid and timolol compositions and methods of using same
TW200305424A (en) 2002-01-29 2003-11-01 Santen Pharmaceutical Co Ltd Glaucoma-treating agent comprising bunazosin and prostaglandin
KR101092048B1 (ko) * 2002-08-29 2011-12-12 산텐 세이야꾸 가부시키가이샤 Ｒｈｏ 키나아제 억제제 및 프로스타글란딘류를 포함하는녹내장 치료제
EP1568382B1 (de) * 2002-11-18 2013-11-06 Santen Pharmaceutical Co., Ltd. HEILMITTEL FÜR GRÜNEN STAR, UMFASSEND Rho-KINASE UND beta-BLOCKER
US7186744B2 (en) * 2003-11-13 2007-03-06 Allergan, Inc. Prostamides for the treatment of glaucoma and related diseases
KR101333990B1 (ko) 2005-07-12 2013-11-27 코와 가부시키가이샤 녹내장을 예방 또는 치료하는 약제
EP2127638A1 (de) * 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Verfahren und Zusammensetzung zur Behandlung von Augenhochdruck und Glaukom
MX2012003296A (es) * 2009-09-17 2012-04-20 Senju Pharma Co Gotas oculares acuosas que contienen latanoprost, y metodo para inhibir la adsorcion de latanoprost a una resina.
US9061034B2 (en) 2010-07-29 2015-06-23 Allergan, Inc. Preservative free bimatoprost and timolol solutions
DK2598118T3 (en) 2010-07-29 2018-12-10 Allergan Inc CONSERVATIVE-FREE BIMATOPROST AND TIMOLOL SOLUTIONS
TW202446398A (zh) 2011-02-04 2024-12-01 日商興和股份有限公司 具眼壓下降作用之醫藥
JP6193655B2 (ja) * 2012-07-13 2017-09-06 参天製薬株式会社 スルホンアミド化合物の組み合わせ
WO2018033854A1 (en) 2016-08-15 2018-02-22 Santen Pharmaceutical Co., Ltd. Ophthalmic composition and a method for treating ocular hypertension and glaucoma
EP4338751B1 (de) 2017-12-21 2025-09-03 Santen Pharmaceutical Co., Ltd. Kombination von sepetaprost und netarsudil zur verwendung in der prophylaxe oder behandlung von glaukom oder augenhochdruck
CA3086445A1 (en) 2017-12-21 2019-06-27 Santen Pharmaceutical Co., Ltd. Omidenepag combination

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4454154A (en) * 1981-06-23 1984-06-12 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
DE3300933A1 (de) * 1983-01-13 1984-07-19 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung von d,l- und d-carazolol als antiglaukommittel sowie arzneimittel, die diese stoffe enthalten
JPH0643313B2 (ja) * 1986-03-13 1994-06-08 ザ・トラステイ−ズ・オブ・コロンビア・ユニヴア−シテイ・イン・ザ・シテイ・オブ・ニユ−・ヨ−ク 緑内障の局所治療用組成物

Also Published As

Publication number Publication date
ES2042625T3 (es) 1993-12-16
DE3871596D1 (de) 1992-07-09
EP0286903B2 (de) 2000-03-29
EP0286903A1 (de) 1988-10-19
ES2042625T5 (es) 2000-07-16
JPS63313728A (ja) 1988-12-21
GR3004794T3 (de) 1993-04-28
CA1314220C (en) 1993-03-09
AU1387088A (en) 1988-10-06
AU607981B2 (en) 1991-03-21
HU211835A9 (en) 1995-12-28
GR3033721T3 (en) 2000-10-31
DE3871596T3 (de) 2000-09-07
EP0286903B1 (de) 1992-06-03
JP2726672B2 (ja) 1998-03-11
DE3871596T2 (de) 1993-01-21

Similar Documents

Publication Publication Date Title
ATE76750T1 (de) Anwendung eines prostaglandins in mischung mit einem adrenergischen blocker zur verminderung des augen-innendruckes.
MX9702349A (es) Usos de derivado de 9-deoxi prostaglandina para tratar glaucoma.
AU6877994A (en) Use of cloprostenol, fluprostenol and their analogues to treat glaucoma and ocular hypertension
DK0752847T3 (da) Ophthalmisk sammensætning med nedsat viskositet
EP0308021A3 (de) Substituierte Thieno[2,3-b]pyrrol-5-sulfonamide als Antiglaukommittel
ECSP034815A (es) "composiciones de timolol y de lipido hipotensivas y los metodos para utilizarlas"
MX9805020A (es) Analogos de prostaglandinas de tetrahidrofurano substituido como hipotensores oculares.
IE811654L (en) Ophthalmic composition
DK0561073T3 (da) Behandling af øjenhypertension
FI911131A0 (fi) Menetelmä viherkaihia estävien 3-aryylikarbonyyli-1-aminoalkyyli-1H-indoliyhdisteiden valmistamiseksi
DE3872701D1 (de) Prostaglandin-derivate zur behandlung von glaucoma oder augenueberdruck.
EP0366279A3 (de) Okulare hypotensive Mittel
TW427913B (en) Eye drop composition comprising pilocarpine and a β-blocking agent and process making the same
HUT64841A (en) Process and composition for treating eyes
AU1545788A (en) A composition for the topical treatment of glaucoma or ocular hypertension
KR920019348A (ko) 탄산탈수효소 억제제 및 β-아드레날린 길항제의 배합물을 포함하는 안과용 조성물
DE69106777D1 (de) Behandlung von intraokularem Druck mit einer ophthalmischen synergistischen Kombination.
DE69116224D1 (de) Behandlung von intraokularem Druck mit einer synergischen Kombination
PT73152A (en) Process for preparing a composition to reduce intra-ocular pressure
DE69320329D1 (de) Topische Antiglaukoma Zusammensetzungen, enthaltend Karbonhydrasehemmer und Beta-Blocker
ATE23112T1 (de) Verwendung von 1-(p-isopropoxyethoxymethylphenoxy)-3-isopropylamino-propan-2-ol zur herstellung eines arzneimittels zur senkung des augeninnendrucks.
IE872994L (en) The use of alpha-21 selective adrenergic receptor agonists¹¹in memory enhancement
DE69829062D1 (de) Verwendung von flunarizin zur topischen behandlung ocularem hochdruck
DE69301387D1 (de) Behandlung des Glaukoms mit synergistischer Kombination
EP0373592A3 (de) Oculoselektive beta-Blocker als Antiglaukommittel

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time